by Blood Advances
Patients who have myeloid malignancies with TP53 mutations often fare poorly after hematopoietic stem cell transplantation (HSCT), but researchers say certain prognostic factors can help identify...
by Rahul Banerjee, MD, FACP
One of the most predictable toxicities of autologous stem cell transplantation (ASCT) for multiple myeloma (MM) — even more so than mucositis — is hair loss.
by BJHaem
More than a decade of animal data culled from a hematopoietic stem and progenitor cell (HSPC) transplantation model is giving scientists insight into long-term clonal dynamics and other safety and...
by ASH Publications
Research shows that as pediatric patients >4 years of age with acute lymphoblastic leukemia (ALL) prepare for allogeneic hematopoietic stem cell transplantation, busulfan-based and...
by Blood Advances
Researchers say pharmacological attenuation of CDC42, a protein coding gene, effectively addresses bone-related problems caused by cytotoxic conditioning required before hematopoietic stem cell...
by Blood Advances
For patients undergoing hematopoietic cell transplantation (HCT) from a 10/10 HLA-matched unrelated donor, scientists agree that the age of the donor matters more than T-cell epitope DP-matching.